
Ensign Peak Advisors’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $678M | Sell |
869,925
-25,975
| -3% | -$20.2M | 1.16% | 11 |
|
2025
Q1 | $740M | Buy |
895,900
+16,762
| +2% | +$13.8M | 1.42% | 10 |
|
2024
Q4 | $679M | Buy |
879,138
+2,726
| +0.3% | +$2.1M | 1.21% | 13 |
|
2024
Q3 | $776M | Sell |
876,412
-15,503
| -2% | -$13.7M | 1.37% | 10 |
|
2024
Q2 | $808M | Sell |
891,915
-35,339
| -4% | -$32M | 1.48% | 9 |
|
2024
Q1 | $721M | Buy |
927,254
+221,327
| +31% | +$172M | 1.32% | 10 |
|
2023
Q4 | $411M | Buy |
705,927
+117,708
| +20% | +$68.6M | 0.81% | 18 |
|
2023
Q3 | $316M | Sell |
588,219
-288,166
| -33% | -$155M | 0.67% | 30 |
|
2023
Q2 | $411M | Buy |
876,385
+167,426
| +24% | +$78.5M | 0.83% | 19 |
|
2023
Q1 | $243M | Buy |
708,959
+290,645
| +69% | +$99.8M | 0.53% | 45 |
|
2022
Q4 | $153M | Buy |
418,314
+30,207
| +8% | +$11.1M | 0.34% | 74 |
|
2022
Q3 | $125M | Buy |
388,107
+109,602
| +39% | +$35.4M | 0.31% | 75 |
|
2022
Q2 | $90.3M | Sell |
278,505
-221,910
| -44% | -$72M | 0.21% | 105 |
|
2022
Q1 | $143M | Sell |
500,415
-143,781
| -22% | -$41.2M | 0.29% | 79 |
|
2021
Q4 | $178M | Sell |
644,196
-33,543
| -5% | -$9.27M | 0.34% | 71 |
|
2021
Q3 | $157M | Sell |
677,739
-327,396
| -33% | -$75.6M | 0.33% | 81 |
|
2021
Q2 | $231M | Sell |
1,005,135
-44,851
| -4% | -$10.3M | 0.47% | 54 |
|
2021
Q1 | $196M | Buy |
1,049,986
+278,594
| +36% | +$52M | 0.42% | 60 |
|
2020
Q4 | $130M | Sell |
771,392
-75,535
| -9% | -$12.8M | 0.3% | 85 |
|
2020
Q3 | $125M | Buy |
846,927
+31,871
| +4% | +$4.72M | 0.32% | 72 |
|
2020
Q2 | $134M | Buy |
815,056
+549,775
| +207% | +$90.3M | 0.36% | 64 |
|
2020
Q1 | $36.8M | Sell |
265,281
-31,253
| -11% | -$4.34M | 0.12% | 131 |
|
2019
Q4 | $39M | Buy |
+296,534
| New | +$39M | 0.1% | 166 |
|